Neuro Spectrum Insights

Neuro Spectrum Insights is a medical device company preparing to commercialize groundbreaking computer analysis technology to enhance clinicians' ability to diagnose neurological and neurodevelopmental disorders. Neuro Spectrum Insights is committed to providing breakthrough software technology to ultimately improve clinicians' ability to more accurately assess various neurodivergent children, starting with autism, and gradually expanding to dyslexia, attention deficit hyperactivity disorder (ADHD), and schizophrenia. Currently, the average age of autism diagnosis is 5 years old, and technological advancements will bring transformative changes for individuals with autism, their families, healthcare providers, caregivers, and the communities they impact. Neuro Spectrum Insights' first product, GyriCalc, is a proprietary patented software solution designed to assist in diagnosing autism by automatically analyzing MRI images to identify early structural markers of neurodevelopmental differences.